NIH consensus conference. Intravenous immunoglobulin. Prevention and treatment of disease.
D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control / Q000628:therapy; D000328:Adult; D016026:Bone Marrow Transplantation; D002648:Child; D004334:Drug Administration Schedule; D006801:Humans; D007116:Immunization, Passive; D007136:Immunoglobulins / Q000008:administration & dosage* / Q000009:adverse effects; D007153:Immunologic Deficiency Syndromes / Q000517:prevention & control / Q000628:therapy; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000517:prevention & control / Q000628:therapy; D007262:Infusions, Intravenous; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000517:prevention & control / Q000628:therapy; D009080:Mucocutaneous Lymph Node Syndrome / Q000517:prevention & control / Q000628:therapy; D011129:Polyradiculoneuropathy / Q000517:prevention & control / Q000628:therapy; D011696:Purpura, Thrombocytopenic / Q000517:prevention & control / Q000628:therapy; D014481:United States
D007136:Immunoglobulins